AusPAR: Ranibizumab (rbe)
Australian Public Assessment Report
Device/Product Name
Lucentis
Active ingredients
Ranibizumab (rbe)
AusPAR Date
Published
Submission Number
PM-2018-04902-1-5
Submission Type
Extension of indications
Decision
Withdrawn